Lanean...
Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups
In immunotherapy dose-finding trials, the optimal dose is usually defined based on both toxicity and response because the relationship between toxicity and response is different than that seen with cytotoxic antineoplastic therapies. In immunotherapy trials, toxicity and response often require a lon...
Gorde:
| Argitaratua izan da: | J Biopharm Stat |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791120/ https://ncbi.nlm.nih.gov/pubmed/31251112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2019.1633654 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|